Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 14
2020 1860
2021 6390
2022 7205
2023 19
Text availability
Article attribute
Article type
Publication date

Search Results

14,082 results
Results by year
Filters applied: . Clear all
Page 1
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, Sabzevari A, Azizi G. Anka AU, et al. Scand J Immunol. 2021 Apr;93(4):e12998. doi: 10.1111/sji.12998. Epub 2020 Dec 3. Scand J Immunol. 2021. PMID: 33190302 Free PMC article. Review.
SARS-CoV-2 is a novel human coronavirus responsible for the Coronavirus disease 2019 (COVID-19) pandemic. Pneumonia and acute respiratory distress syndrome are the major complications of COVID-
SARS-CoV-2 is a novel human coronavirus responsible for the Coronavirus disease 2019 (COVID
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J, Minko T. Majumder J, et al. AAPS J. 2021 Jan 5;23(1):14. doi: 10.1208/s12248-020-00532-2. AAPS J. 2021. PMID: 33400058 Free PMC article. Review.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with …
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respirat
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, Simmons R, Cottrell S, Roberts R, O'Doherty M, Brown K, Cameron C, Stockton D, McMenamin J, Ramsay M. Lopez Bernal J, et al. BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088. BMJ. 2021. PMID: 33985964 Free PMC article.
INTERVENTIONS: Vaccination with BNT162b2 or ChAdOx1-S. MAIN OUTCOME MEASURES: Primary outcomes were polymerase chain reaction confirmed symptomatic SARS-CoV-2 infections, admissions to hospital for covid-19, and deaths with covid- …
INTERVENTIONS: Vaccination with BNT162b2 or ChAdOx1-S. MAIN OUTCOME MEASURES: Primary outcomes were polymerase chain reaction confirm …
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O'Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Feikin DR, et al. Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23. Lancet. 2022. PMID: 35202601 Free PMC article.
We did a systematic review of preprint and peer-reviewed published article databases from June 17, 2021, to Dec 2, 2021. Randomised controlled trials of COVID-19 vaccine efficacy and observational studies of COVID-19 vaccine effectiveness were e …
We did a systematic review of preprint and peer-reviewed published article databases from June 17, 2021, to Dec 2, 2021. Randomised c …
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.
Raman R, Patel KJ, Ranjan K. Raman R, et al. Biomolecules. 2021 Jul 6;11(7):993. doi: 10.3390/biom11070993. Biomolecules. 2021. PMID: 34356617 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, which has been a topic of major concern for global
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic
Coronavirus vaccine development: from SARS and MERS to COVID-19.
Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Li YD, et al. J Biomed Sci. 2020 Dec 20;27(1):104. doi: 10.1186/s12929-020-00695-2. J Biomed Sci. 2020. PMID: 33341119 Free PMC article. Review.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pan
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of
COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management.
Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, Sohail MR, Mahmood SF, Ochani R, Hussham Arshad M, Kumar A, Surani S. Ochani R, et al. Infez Med. 2021 Mar 1;29(1):20-36. Infez Med. 2021. PMID: 33664170 Free article. Review.
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative pathogen for the COVID-19, first emerged in Wuhan, China, in December 2019 and by March 2020, it was declared a pandemic
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the causative p
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development.
Sreepadmanabh M, Sahu AK, Chande A. Sreepadmanabh M, et al. J Biosci. 2020;45(1):148. doi: 10.1007/s12038-020-00114-6. J Biosci. 2020. PMID: 33410425 Free PMC article. Review.
An unprecedented worldwide spread of the SARS-CoV-2 has imposed severe challenges on healthcare facilities and medical infrastructure. The global research community faces urgent calls for the development of rapid diagnostic tools, effective treatment p …
An unprecedented worldwide spread of the SARS-CoV-2 has imposed severe challenges on healthcare facilities and m …
COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts.
Rashedi R, Samieefar N, Masoumi N, Mohseni S, Rezaei N. Rashedi R, et al. J Med Virol. 2022 Apr;94(4):1294-1299. doi: 10.1002/jmv.27463. Epub 2021 Nov 30. J Med Virol. 2022. PMID: 34796525 Free PMC article. Review.
The search for developing effective vaccines against SARS-CoV-2 began with the start of the COVID-19 pandemic, and the first vaccine dose was administered in December 2020. Today, full vaccination of most of the world's population …
The search for developing effective vaccines against SARS-CoV-2 began with the start of the COVID-19
Emerging treatment strategies for COVID-19 infection.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis IG, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Gavriatopoulou M, et al. Clin Exp Med. 2021 May;21(2):167-179. doi: 10.1007/s10238-020-00671-y. Epub 2020 Oct 30. Clin Exp Med. 2021. PMID: 33128197 Free PMC article. Review.
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused by SARS-CoV-2 characterized as …
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and has led to a w …
14,082 results
You have reached the last available page of results. Please see the User Guide for more information.